Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Silvia Sookoian, Carlos J. Pirola

Clin Mol Hepatol. 2023;29(Suppl):S184-S195. Published online December 5, 2022

DOI: https://doi.org/10.3350/cmh.2022.0318

View: 4393 Download: 190 Web of Science: 11 Crossref: 13

Carlos J. Pirola, Silvia Sookoian

Clin Mol Hepatol. 2022;28(4):935-938. Published online June 24, 2022

DOI: https://doi.org/10.3350/cmh.2022.0175

View: 4747 Download: 147 Web of Science: 7 Crossref: 6

Silvia Sookoian, Carlos J. Pirola

Clin Mol Hepatol. 2017;23(1):1-12. Published online March 9, 2017

DOI: https://doi.org/10.3350/cmh.2016.0109

View: 18523 Download: 611 Web of Science: 153 Crossref: 152

Baokai Sun, Xiaoqian Ding, Jie Tan, Jie Zhang, Xueru Chu, Shuimi Zhang, Shousheng Liu, Zhenzhen Zhao, Shiying Xuan, Yongning Xin, Likun Zhuang

Received April 16, 2024 Accepted July 26, 2024

DOI: https://doi.org/10.3350/cmh.2024.0268 [Accepted]

View: 644 Download: 131

Baokai Sun, Likun Zhuang

Received September 3, 2024 Accepted September 7, 2024

DOI: https://doi.org/10.3350/cmh.2024.0744 [Accepted]

View: 225 Download: 37

1 |

Viewed By 4998	MAFLD: How is it different from NAFLD?
Viewed By 4841	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4774	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4491	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4445	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 214	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 133	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 117	MAFLD: How is it different from NAFLD?
Cited By 95	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search